Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Sapacitabine

1 Open Trial

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCHEM1096

10/24/2011

A Phase III Randomized Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia